Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 13/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL570762 | 0.87 | FDPS (0.39) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL16816993 | 0.78 | FDPS (0.58) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| Phosphoric Acid SCHEMBL29565136 | 0.75 | FDPS (0.42) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL4060154 | 0.74 | FDPS (0.42) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL27602395 | 0.74 | — | — | |
| SCHEMBL5490027 | 0.69 | LMNA (0.47) | FDPSSMPD1GGPS1LMNA | |
| SCHEMBL8718782 | 0.69 | GGPS1 (0.50) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL1768259 | 0.69 | FDPS (0.43) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL6296955 | 0.69 | FDPS (0.43) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL246809 | 0.69 | FDPS (0.43) | FDPSSMPD1GGPS1LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4362158-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION, NON-AQUEOUS SODIUM-ION BATTERY, NON-AQUEOUS POTASSIUM-ION BATTERY, METHOD FOR MANUFACTURING NON-AQUEOUS SODIUM-ION BATTERY, AND METHOD FOR MANUFACTURING NON-AQUEOUS POTASSIUM-ION BATTERY | Central Glass Co., Ltd. (JP) | 2024-05-01 | — | — | EP | disclosed |
| EP-2595934-A1 | METHOD OF METALLIZING MINERAL FIBERS AND THEIR USE | Saint-Gobain Isover (FR) | 2013-05-29 | — | — | EP | disclosed |
| WO-2012010655-A1 | METHOD OF METALLIZING MINERAL FIBERS AND THEIR USE | SAINT-GOBAIN ISOVER (FR) | 2012-01-26 | — | — | WO | disclosed |
| EP-0831869-B1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS IN (US) | 2006-02-08 | — | — | EP | disclosed |
| EP-1478690-A1 | POLYMETHACRYLIMIDE PLASTIC FOAM MATERIALS WITH REDUCED INFLAMMABILITY IN ADDITION TO A METHOD FOR THE PRODUCTION THEREOF | Röhm GmbH & Co. KG (DE) | 2004-11-24 | — | — | EP | disclosed |
| WO-2003072647-A1 | POLYMETHACRYLIMIDE PLASTIC FOAM MATERIALS WITH REDUCED INFLAMMABILITY IN ADDITION TO A METHOD FOR THE PRODUCTION THEREOF | Röhm GmbH & Co. KG (DE) | 2003-09-04 | — | — | WO | disclosed |
| WO-2002034821-A1 | COMPOSITIONS FOR THE PRODUCTION OF POLY(METH)ACRYLIMIDE FOAMS CONTAINING EXPANDED GRAPHITE | Röhm GmbH & Co. KG (DE) | 2002-05-02 | — | — | WO | disclosed |
| EP-0831869-A4 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS IN (US) | 1999-04-21 | — | — | EP | disclosed |
| US-5880111-A | CHEMOTHERAPWUTIC AGENTS; TREATING PERIODONTAL DISEASE AND URINARY TRACT INFECTIONS | FARCASIU DAN (US) | 1999-03-09 | — | — | US | disclosed |
| EP-0831869-A1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | Elizanor Biopharmaceuticals, Inc. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040190-A1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-5428028-A | Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor | E. R. SQUIBB & SONS, INC. (US) | 1995-06-27 | — | — | US | disclosed |
| EP-0514124-A2 | Use of phosphonomethylphosphinate squalene synthetase inhibitors for the manufacture of a medicament for the lowering cholesterol | E.R. SQUIBB & SONS, INC. (US) | 1992-11-19 | — | — | EP | disclosed |
| US-5108994-A | Synergistic with interferon; herpes virus | BEECHAM GROUP P.L.C. (GB) | 1992-04-28 | — | — | US | disclosed |
| EP-0245207-B1 | FLAME-RESISTANT POLYMER COMPOSITIONS CONTAINING SALTS OF PHOSPHONIC ACIDS | CIBA-GEIGY AG (CH) | 1992-02-05 | — | — | EP | disclosed |
| US-4972011-A | POLYMER OF AN ALUMINUM SALT AND A PHOSPHONIC ACID, FIREPROOFING | CIBA-GEIGY CORPORATION (US) | 1990-11-20 | — | — | US | disclosed |
| EP-0148158-B1 | PROCESS FOR ELUTING INDIUM FROM A CHELATE RESIN CONTAINING ADSORBED INDIUM | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-04-20 | — | — | EP | disclosed |
| EP-0245207-A2 | Flame-resistant polymer compositions containing salts of phosphonic acids | CIBA-GEIGY AG (CH) | 1987-11-11 | — | — | EP | disclosed |